Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BFTI announces that negotiations have been put on hold with INR.


SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Oct. 29, 1996--Bio Fluorescent Technologies Inc. (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 BB:BFTI BFTI Brownfields Tax Incentive ) (BFTI) Tuesday announced that it has ceased negotiations with INR INR

In currencies, this is the abbreviation for the Indian Rupee.

Notes:
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion.
, a Vancouver, British Columbia British Columbia, province (2001 pop. 3,907,738), 366,255 sq mi (948,600 sq km), including 6,976 sq mi (18,068 sq km) of water surface, W Canada. Geography
 biotech company.

It was determined by INR that under the policies of the Vancouver Stock Exchange Vancouver Stock Exchange (VSE)

A securities and options exchange in Vancouver, British Columbia, (Canada), specializing in venture capital companies.


Vancouver Stock Exchange

See Canadian Venture Exchange (CDNX).
 the company would not be allowed to enter into a merger transaction for a period of one year following INR's amalgamation, which was completed less than 6 months ago.

BFTI's management will monitor INR's progress and track its technology. BFTI's scientific advisors believe that INR's science has significant potential for successful AIDS treatment. Possible licensing of INR's patented mono-clonal antibody technology is included in BFTI's plans for an ongoing relationship with INR.

BFTI continues to review various merger and acquisition opportunities and is aggressively pursuing this avenue of expansion. BFTI is proceeding with development of the multi-viral test system that is the basis for the company's technology.

CONTACT: Bio Fluorescent Technologies Inc., Scottsdale

George, 800/870-1233
COPYRIGHT 1996 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 29, 1996
Words:159
Previous Article:Ameritech Chooses Autodesk WorkCenter as Document Management Platform; Consolidation Demands Secure Access to AutoCAD Engineering Drawings, Microsoft...
Next Article:DRS subsidiary now offers new Autoloader Library for digital tape drive.
Topics:



Related Articles
Geriatric Pharmacy Educational Series. (Product Spotlight).
Selected abstracts. (*) (Special Feature).
FP4 Utility of and patient satisfaction with a point-of-care anticoagulation monitoring system in a family practice residency program. (Family...
Preliminary experience with the use of recombinant factor VIIa to treat coagulation disturbances in pediatric patients. (Original Article).
Medication-monitoring lawsuit: case study and lessons learned; another real-life case in nursing home litigation. (Feature Article).
Clinical correlation between effective anticoagulants and risk of stroke: are we using evidence-based strategies?
Analyze this: inside the one spy agency that got pre-war intelligence on Iraq--and much else--right.
Preventing warfarin-related bleeding.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles